HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

E Javier Pretell Selected Research

Neurocysticercosis

1/2022Improved Diagnosis of Viable Parenchymal Neurocysticercosis by Combining Antibody Banding Patterns on Enzyme-Linked Immunoelectrotransfer Blot (EITB) with Antigen Enzyme-Linked Immunosorbent Assay (ELISA).
11/2019Albendazole Sulfoxide Plasma Levels and Efficacy of Antiparasitic Treatment in Patients With Parenchymal Neurocysticercosis.
1/2018Antibody Banding Patterns of the Enzyme-Linked Immunoelectrotransfer Blot and Brain Imaging Findings in Patients With Neurocysticercosis.
1/2016Cysticidal Efficacy of Combined Treatment With Praziquantel and Albendazole for Parenchymal Brain Cysticercosis.
3/2015Combined antiparasitic treatment for neurocysticercosis - Authors' reply.
8/2014Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial.
10/2013Parasite antigen in serum predicts the presence of viable brain parasites in patients with apparently calcified cysticercosis only.
7/2011Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis.
5/2009Detection of Taenia solium antigens and anti-T. solium antibodies in paired serum and cerebrospinal fluid samples from patients with intraparenchymal or extraparenchymal neurocysticercosis.
2/2006Efficacy of a 3-day course of albendazole treatment in patients with a single neurocysticercosis cyst.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


E Javier Pretell Research Topics

Disease

12Neurocysticercosis
01/2022 - 01/2004
9Cysts
01/2022 - 01/2004
4Cysticercosis
01/2016 - 07/2011
3Seizures (Absence Seizure)
11/2021 - 01/2004
2Infections
01/2022 - 01/2018
1Edema (Dropsy)
02/2015
1Echinococcosis (Hydatid Cysts)
07/2011
1Tuberculoma
01/2005
1Tuberculosis (Tuberculoses)
01/2005

Drug/Important Bio-Agent (IBA)

8Antiparasitic Agents (Antiparasitics)IBA
11/2021 - 01/2004
7Albendazole (Albenza)FDA Link
11/2021 - 01/2004
4Praziquantel (Biltricide)FDA Link
11/2019 - 07/2011
3Anticonvulsants (Antiepileptic Drugs)IBA
01/2022 - 01/2004
3Dexamethasone (Maxidex)FDA LinkGeneric
11/2021 - 01/2004
2AntigensIBA
01/2022 - 10/2013
2EnzymesIBA
01/2022 - 01/2018
2AntibodiesIBA
01/2018 - 05/2009
1ImmunosorbentsIBA
01/2022
1albendazole sulfoxideIBA
11/2019
1brain synaptic membrane glycoprotein gp 50 (GP50)IBA
01/2018
1Proteins (Proteins, Gene)FDA Link
01/2018
1Biomarkers (Surrogate Marker)IBA
02/2015
1SteroidsIBA
09/2014
1N-acetylaspartate (N-acetyl aspartate)IBA
01/2005
1Choline (Choline Chloride)IBA
01/2005
1Protons (Proton)IBA
01/2005
1LipidsIBA
01/2005
1CreatineIBA
01/2005
1PlacebosIBA
01/2004

Therapy/Procedure

4Therapeutics
11/2019 - 01/2004
2Aftercare (After-Treatment)
11/2021 - 01/2004
1Retreatment
11/2021